Study of Coronary Plaque Rupture in Heart Attack Following Surgery Using Optical Coherence Tomography (OCT)
OPTIMUS
OCT Plaque and Thrombus IMaging in Patients Who Underwent Non-cardiac Surgery
1 other identifier
observational
60
1 country
1
Brief Summary
Background It is commonly believed that a heart attack is caused by rupture of a plaque in the wall of the coronary artery, resulting in blood clots which impede blood flow. Currently, the investigators do not know whether heart attacks in patients who had a recent surgery are caused by the same disease process as those who did not have any surgery. This study will inform the investigators of very vital information about the cause of surgery-related heart attacks by taking images of coronary arteries using Optical Coherence Tomography (OCT). Images will also be taken from heart attack patients who did not have recent surgery, and the two groups will be compared. OCT imaging OCT is a relatively new imaging technology which is much better at taking images of the inside of the artery. OCT imaging procedure is carried out at the time of scheduled coronary angiogram, where a catheter with a mini-camera at its tip is advanced into the coronary artery, it will record video images of a length of the artery. These images will take approximately 3-4 seconds to obtain. Besides the OCT imaging being performed, the rest of the angiogram procedure is carried out in exactly the same way as it would normally proceed. The OCT study will provide doctors with new information about the cause of surgery-related heart attacks, and will guide doctors in treating and preventing heart attacks in patients who undergo surgery. Hypothesis The investigators hypothesize that features of acute plaque rupture will be more common in patients with non-surgery related heart attacks compared to those which occur following surgery. Design Two groups of patients will be recruited(\>20 in each group):
- 1.non-surgery related heart attack patients
- 2.patients who suffered from a heart attack following an operation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2012
CompletedFirst Posted
Study publicly available on registry
March 15, 2012
CompletedStudy Start
First participant enrolled
April 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedNovember 4, 2014
November 1, 2014
2.8 years
March 9, 2012
November 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evidence of plaque rupture by OCT imaging
OCT evidence of plaque rupture, presence of white or red thrombus will be collected at the time of coronary angiography.
Day 1
Secondary Outcomes (1)
Other features OCT features of atherosclerotic plaques.
Day 1
Study Arms (2)
Peri-operative NSTEMI patients
Patients with POMI undergoing cardiac catheterization within 72 hours of first troponin elevation and within 2 weeks of their non-cardiac surgery.
Non-surgery related NSTEMI patients
Patients with NSTEMI undergoing cardiac catheterization within 72 hours of symptom onset.
Eligibility Criteria
NSTEMI and peri-operative MI patients will be screened in the catheterisation laboratory. In addition, peri-operative MI patients will be screened in hospital wards, where patient referral for cardiac catheterisation will be based on clinical indications.
You may qualify if:
- Age over 18
- Referred to coronary angiography with the view of revascularisation
You may not qualify if:
- ST elevation myocardial infarction
- Shock defined as the systolic blood pressure \<90mmHg and tachycardia with heart rate \>100 with evidence of systemic organ hypoperfusion.
- Inability to give consent
- Previous coronary artery bypass surgery due to the limited anticipated feasibility of OCT imaging in native vessels of patients with prior bypass grafts.
- PCI with stenting in the previous 6 months due to the elevated risk of stent related complications (thrombosis or restenosis) as the potential cause of the NSTEMI.
- GFR \<35 due to need for additional 40-60 cc contrast during OCT imaging.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Victar Hsiehlead
Study Sites (1)
Hamilton General Hospital
Hamilton, Ontario, L8L 2X2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Victar Hsieh, MBBS PhD
Hamilton Health Services
- PRINCIPAL INVESTIGATOR
Tej Sheth, BArts SC MD
Hamilton Health Services
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Interventional fellow
Study Record Dates
First Submitted
March 9, 2012
First Posted
March 15, 2012
Study Start
April 1, 2012
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
November 4, 2014
Record last verified: 2014-11